524 related articles for article (PubMed ID: 29393357)
1. Damage to dopaminergic neurons by oxidative stress in Parkinson's disease (Review).
Guo JD; Zhao X; Li Y; Li GR; Liu XL
Int J Mol Med; 2018 Apr; 41(4):1817-1825. PubMed ID: 29393357
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria-mediated damage to dopaminergic neurons in Parkinson's disease (Review).
Liu XL; Wang YD; Yu XM; Li DW; Li GR
Int J Mol Med; 2018 Feb; 41(2):615-623. PubMed ID: 29207041
[TBL] [Abstract][Full Text] [Related]
3. IDH2 deficiency promotes mitochondrial dysfunction and dopaminergic neurotoxicity: implications for Parkinson's disease.
Kim H; Kim SH; Cha H; Kim SR; Lee JH; Park JW
Free Radic Res; 2016 Aug; 50(8):853-60. PubMed ID: 27142242
[TBL] [Abstract][Full Text] [Related]
4. Current perspective of mitochondrial biology in Parkinson's disease.
Ammal Kaidery N; Thomas B
Neurochem Int; 2018 Jul; 117():91-113. PubMed ID: 29550604
[TBL] [Abstract][Full Text] [Related]
5. Enhanced translocation of TRIM32 to mitochondria sensitizes dopaminergic neuronal cells to apoptosis during stress conditions in Parkinson's disease.
Goyani S; Shinde A; Shukla S; Saranga MV; Currim F; Mane M; Singh J; Roy M; Gohel D; Chandak N; Vasiyani H; Singh R
FEBS J; 2024 Jun; 291(12):2636-2655. PubMed ID: 38317520
[TBL] [Abstract][Full Text] [Related]
6. Oxidative Modification and Its Implications for the Neurodegeneration of Parkinson's Disease.
Zhao J; Yu S; Zheng Y; Yang H; Zhang J
Mol Neurobiol; 2017 Mar; 54(2):1404-1418. PubMed ID: 26843115
[TBL] [Abstract][Full Text] [Related]
7. Determinants of dopaminergic neuron loss in Parkinson's disease.
Surmeier DJ
FEBS J; 2018 Oct; 285(19):3657-3668. PubMed ID: 30028088
[TBL] [Abstract][Full Text] [Related]
8. NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease.
Choi DH; Cristóvão AC; Guhathakurta S; Lee J; Joh TH; Beal MF; Kim YS
Antioxid Redox Signal; 2012 May; 16(10):1033-45. PubMed ID: 22098189
[TBL] [Abstract][Full Text] [Related]
9. The role of oxidative stress in Parkinson's disease.
Dias V; Junn E; Mouradian MM
J Parkinsons Dis; 2013; 3(4):461-91. PubMed ID: 24252804
[TBL] [Abstract][Full Text] [Related]
10. Parkin loss-of-function pathology: Premature neuronal senescence induced by high levels of reactive oxygen species?
Buhlman LM
Mech Ageing Dev; 2017 Jan; 161(Pt A):112-120. PubMed ID: 27374431
[TBL] [Abstract][Full Text] [Related]
11. SUMO-regulated mitochondrial function in Parkinson's disease.
Guerra de Souza AC; Prediger RD; Cimarosti H
J Neurochem; 2016 Jun; 137(5):673-86. PubMed ID: 26932327
[TBL] [Abstract][Full Text] [Related]
12. Damage to dopaminergic neurons is mediated by proliferating cell nuclear antigen through the p53 pathway under conditions of oxidative stress in a cell model of Parkinson's disease.
Li DW; Li GR; Zhang BL; Feng JJ; Zhao H
Int J Mol Med; 2016 Feb; 37(2):429-35. PubMed ID: 26677001
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of the Mitochondrial Unfolded Protein Response Induces Non-Apoptotic Dopaminergic Neurodegeneration in
Martinez BA; Petersen DA; Gaeta AL; Stanley SP; Caldwell GA; Caldwell KA
J Neurosci; 2017 Nov; 37(46):11085-11100. PubMed ID: 29030433
[TBL] [Abstract][Full Text] [Related]
14. DNA Damage and Parkinson's Disease.
Pfeifer GP
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673772
[TBL] [Abstract][Full Text] [Related]
15. Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?
Bisaglia M; Filograna R; Beltramini M; Bubacco L
Ageing Res Rev; 2014 Jan; 13():107-14. PubMed ID: 24389159
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
18. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress.
Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM
Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317
[TBL] [Abstract][Full Text] [Related]
19. Adaptation within mitochondrial oxidative phosphorylation supercomplexes and membrane viscosity during degeneration of dopaminergic neurons in an animal model of early Parkinson's disease.
Kuter K; Kratochwil M; Berghauzen-Maciejewska K; Głowacka U; Sugawa MD; Ossowska K; Dencher NA
Biochim Biophys Acta; 2016 Apr; 1862(4):741-753. PubMed ID: 26844379
[TBL] [Abstract][Full Text] [Related]
20. Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.
Sanders LH; Timothy Greenamyre J
Free Radic Biol Med; 2013 Sep; 62():111-120. PubMed ID: 23328732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
